ELAVL1 and nasopharyngeal carcinoma: Furthermore, another research uncovered that individuals with elevated ELAVL1 expression had shorter overall survival and progression-free survival compared to those with low ELAVL1 expression, supporting the clinical relevance of ELAVL1 in nasopharyngeal carcinoma prognosis(Tian et al. 2023).